About US
Contact us
-
Scientists at Oxford University begin first booster Ebola vaccine trialsScientists at Oxford University have started first booster Ebola vaccine trials to test its safety and evaluate its potential to further increase the immune responses seen in healthy volunteers. The2014/12/8
-
GSK reveals plans to cut sales and research jobs in USGlaxoSmithKline (GSK) has reportedly revealed plans to cut 'several hundred' sales and research jobs in the US. The cuts are part of its global restructuring strategy and cost-saving programme. In a2014/12/8
-
Nanotech takes on antimicrobial resistanceThere are few threats to global health more serious than antimicrobial resistance (AMR). Given that antibiotics represent one of the core pillars of modern medicine, at present there is no easy answer2014/12/8
-
MRIGlobal awarded $3 million contract to provide HPV vaccineMRIGlobal today announced that it has been awarded a $3 million contract amendment from the National Cancer Institute's PREVENT Cancer Program to provide a vaccine for the Human Papillomavirus or HPV,2014/12/5
-
Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tabletsMylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) for its New Drug Applications (2014/12/5
-
Amgen’s Blincyto approved to treat Ph- relapsed or refractory B-cell precursor ALLAmgen has received approval from US Food and Drug Administration (FDA) for its Blincyto (blinatumomab) to treat patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precu2014/12/5
-
Roquette Pharma - Global Supplier of Pharmaceutical Excipients and ActivesRoquette is a long-established supplier of raw materials, excipients and actives to the pharmaceutical and cosmetic industries, which also benefit from its valuable services. Oral dosage forms are st2014/12/3
-
Pfizer acquires Baxter's marketed vaccines portfolio for $635mUS-based drug maker Pfizer has completed the acquisition of marketed vaccines portfolio from Baxter International for $635m. As part of the deal, Pfizer also acquired a portion of Baxter's facility i2014/12/3
-
UK Medical Research Council scientists create world's first synthetic enzymesScientists at the UK's Medical Research Council (MRC) have created the world's first enzymes made from artificial genetic material, which are capable of triggering chemical reactions in the laboratory2014/12/3
-
Daiichi and UCB Biopharma partner to introduce epilepsy treatment Lacosamide in JapanJapan-based Daiichi Sankyo has signed an agreement with UCB Biopharma to jointly commercialise Lacosamide for the treatment of patients with epilepsy in Japan.As part of the deal, UCB will manufacture2014/12/2